Global Human Vaccines Administered Orally Market Research Report 2022

Global Human Vaccines Administered Orally Market Research Report 2022

Table of Contents
1 Human Vaccines Administered Orally Market Overview
1.1 Product Overview and Scope of Human Vaccines Administered Orally
1.2 Human Vaccines Administered Orally Segment by Type
1.2.1 Global Human Vaccines Administered Orally Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 Rotavirus Vaccine
1.2.3 Cholera Vaccine
1.2.4 Oral Polio Vaccine
1.3 Human Vaccines Administered Orally Segment by Application
1.3.1 Global Human Vaccines Administered Orally Sales Comparison by Application: (2022-2028)
1.3.2 Public
1.3.3 Private
1.4 Global Human Vaccines Administered Orally Market Size Estimates and Forecasts
1.4.1 Global Human Vaccines Administered Orally Revenue 2017-2028
1.4.2 Global Human Vaccines Administered Orally Sales 2017-2028
1.4.3 Human Vaccines Administered Orally Market Size by Region: 2017 Versus 2021 Versus 2028
2 Human Vaccines Administered Orally Market Competition by Manufacturers
2.1 Global Human Vaccines Administered Orally Sales Market Share by Manufacturers (2017-2022)
2.2 Global Human Vaccines Administered Orally Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Human Vaccines Administered Orally Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Human Vaccines Administered Orally Manufacturing Sites, Area Served, Product Type
2.5 Human Vaccines Administered Orally Market Competitive Situation and Trends
2.5.1 Human Vaccines Administered Orally Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Human Vaccines Administered Orally Players Market Share by Revenue
2.5.3 Global Human Vaccines Administered Orally Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Human Vaccines Administered Orally Retrospective Market Scenario by Region
3.1 Global Human Vaccines Administered Orally Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Human Vaccines Administered Orally Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Human Vaccines Administered Orally Market Facts & Figures by Country
3.3.1 North America Human Vaccines Administered Orally Sales by Country
3.3.2 North America Human Vaccines Administered Orally Revenue by Country
3.3.3 United States
3.3.4 Canada
3.4 Europe Human Vaccines Administered Orally Market Facts & Figures by Country
3.4.1 Europe Human Vaccines Administered Orally Sales by Country
3.4.2 Europe Human Vaccines Administered Orally Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Human Vaccines Administered Orally Market Facts & Figures by Region
3.5.1 Asia Pacific Human Vaccines Administered Orally Sales by Region
3.5.2 Asia Pacific Human Vaccines Administered Orally Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Human Vaccines Administered Orally Market Facts & Figures by Country
3.6.1 Latin America Human Vaccines Administered Orally Sales by Country
3.6.2 Latin America Human Vaccines Administered Orally Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Human Vaccines Administered Orally Market Facts & Figures by Country
3.7.1 Middle East and Africa Human Vaccines Administered Orally Sales by Country
3.7.2 Middle East and Africa Human Vaccines Administered Orally Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Human Vaccines Administered Orally Historic Market Analysis by Type
4.1 Global Human Vaccines Administered Orally Sales Market Share by Type (2017-2022)
4.2 Global Human Vaccines Administered Orally Revenue Market Share by Type (2017-2022)
4.3 Global Human Vaccines Administered Orally Price by Type (2017-2022)
5 Global Human Vaccines Administered Orally Historic Market Analysis by Application
5.1 Global Human Vaccines Administered Orally Sales Market Share by Application (2017-2022)
5.2 Global Human Vaccines Administered Orally Revenue Market Share by Application (2017-2022)
5.3 Global Human Vaccines Administered Orally Price by Application (2017-2022)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Corporation Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck Human Vaccines Administered Orally Sales, Revenue and Gross Margin (2017-2022)
6.1.4 Merck Human Vaccines Administered Orally Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 GSK
6.2.1 GSK Corporation Information
6.2.2 GSK Description and Business Overview
6.2.3 GSK Human Vaccines Administered Orally Sales, Revenue and Gross Margin (2017-2022)
6.2.4 GSK Human Vaccines Administered Orally Product Portfolio
6.2.5 GSK Recent Developments/Updates
6.3 Sanofi
6.3.1 Sanofi Corporation Information
6.3.2 Sanofi Description and Business Overview
6.3.3 Sanofi Human Vaccines Administered Orally Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Sanofi Human Vaccines Administered Orally Product Portfolio
6.3.5 Sanofi Recent Developments/Updates
6.4 Lanzhou Institute
6.4.1 Lanzhou Institute Corporation Information
6.4.2 Lanzhou Institute Description and Business Overview
6.4.3 Lanzhou Institute Human Vaccines Administered Orally Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Lanzhou Institute Human Vaccines Administered Orally Product Portfolio
6.4.5 Lanzhou Institute Recent Developments/Updates
6.5 Serum Institute
6.5.1 Serum Institute Corporation Information
6.5.2 Serum Institute Description and Business Overview
6.5.3 Serum Institute Human Vaccines Administered Orally Sales, Revenue and Gross Margin (2017-2022)
6.5.4 Serum Institute Human Vaccines Administered Orally Product Portfolio
6.5.5 Serum Institute Recent Developments/Updates
6.6 Valneva
6.6.1 Valneva Corporation Information
6.6.2 Valneva Description and Business Overview
6.6.3 Valneva Human Vaccines Administered Orally Sales, Revenue and Gross Margin (2017-2022)
6.6.4 Valneva Human Vaccines Administered Orally Product Portfolio
6.6.5 Valneva Recent Developments/Updates
6.7 Shanghai United Cell
6.6.1 Shanghai United Cell Corporation Information
6.6.2 Shanghai United Cell Description and Business Overview
6.6.3 Shanghai United Cell Human Vaccines Administered Orally Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Shanghai United Cell Human Vaccines Administered Orally Product Portfolio
6.7.5 Shanghai United Cell Recent Developments/Updates
6.8 Bibcol
6.8.1 Bibcol Corporation Information
6.8.2 Bibcol Description and Business Overview
6.8.3 Bibcol Human Vaccines Administered Orally Sales, Revenue and Gross Margin (2017-2022)
6.8.4 Bibcol Human Vaccines Administered Orally Product Portfolio
6.8.5 Bibcol Recent Developments/Updates
6.9 PaxVax
6.9.1 PaxVax Corporation Information
6.9.2 PaxVax Description and Business Overview
6.9.3 PaxVax Human Vaccines Administered Orally Sales, Revenue and Gross Margin (2017-2022)
6.9.4 PaxVax Human Vaccines Administered Orally Product Portfolio
6.9.5 PaxVax Recent Developments/Updates
6.10 Vabiotech
6.10.1 Vabiotech Corporation Information
6.10.2 Vabiotech Description and Business Overview
6.10.3 Vabiotech Human Vaccines Administered Orally Sales, Revenue and Gross Margin (2017-2022)
6.10.4 Vabiotech Human Vaccines Administered Orally Product Portfolio
6.10.5 Vabiotech Recent Developments/Updates
6.11 Tiantan Biological
6.11.1 Tiantan Biological Corporation Information
6.11.2 Tiantan Biological Human Vaccines Administered Orally Description and Business Overview
6.11.3 Tiantan Biological Human Vaccines Administered Orally Sales, Revenue and Gross Margin (2017-2022)
6.11.4 Tiantan Biological Human Vaccines Administered Orally Product Portfolio
6.11.5 Tiantan Biological Recent Developments/Updates
6.12 EuBiologics
6.12.1 EuBiologics Corporation Information
6.12.2 EuBiologics Human Vaccines Administered Orally Description and Business Overview
6.12.3 EuBiologics Human Vaccines Administered Orally Sales, Revenue and Gross Margin (2017-2022)
6.12.4 EuBiologics Human Vaccines Administered Orally Product Portfolio
6.12.5 EuBiologics Recent Developments/Updates
6.13 Panacea Biotec Ltd
6.13.1 Panacea Biotec Ltd Corporation Information
6.13.2 Panacea Biotec Ltd Human Vaccines Administered Orally Description and Business Overview
6.13.3 Panacea Biotec Ltd Human Vaccines Administered Orally Sales, Revenue and Gross Margin (2017-2022)
6.13.4 Panacea Biotec Ltd Human Vaccines Administered Orally Product Portfolio
6.13.5 Panacea Biotec Ltd Recent Developments/Updates
6.14 Bio-Med
6.14.1 Bio-Med Corporation Information
6.14.2 Bio-Med Human Vaccines Administered Orally Description and Business Overview
6.14.3 Bio-Med Human Vaccines Administered Orally Sales, Revenue and Gross Margin (2017-2022)
6.14.4 Bio-Med Human Vaccines Administered Orally Product Portfolio
6.14.5 Bio-Med Recent Developments/Updates
6.15 Halfkin Bio-Pharmaceuticals
6.15.1 Halfkin Bio-Pharmaceuticals Corporation Information
6.15.2 Halfkin Bio-Pharmaceuticals Human Vaccines Administered Orally Description and Business Overview
6.15.3 Halfkin Bio-Pharmaceuticals Human Vaccines Administered Orally Sales, Revenue and Gross Margin (2017-2022)
6.15.4 Halfkin Bio-Pharmaceuticals Human Vaccines Administered Orally Product Portfolio
6.15.5 Halfkin Bio-Pharmaceuticals Recent Developments/Updates
7 Human Vaccines Administered Orally Manufacturing Cost Analysis
7.1 Human Vaccines Administered Orally Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Human Vaccines Administered Orally
7.4 Human Vaccines Administered Orally Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Human Vaccines Administered Orally Distributors List
8.3 Human Vaccines Administered Orally Customers
9 Human Vaccines Administered Orally Market Dynamics
9.1 Human Vaccines Administered Orally Industry Trends
9.2 Human Vaccines Administered Orally Market Drivers
9.3 Human Vaccines Administered Orally Market Challenges
9.4 Human Vaccines Administered Orally Market Restraints
10 Global Market Forecast
10.1 Human Vaccines Administered Orally Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Human Vaccines Administered Orally by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Human Vaccines Administered Orally by Type (2023-2028)
10.2 Human Vaccines Administered Orally Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Human Vaccines Administered Orally by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Human Vaccines Administered Orally by Application (2023-2028)
10.3 Human Vaccines Administered Orally Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Human Vaccines Administered Orally by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Human Vaccines Administered Orally by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Human Vaccines Administered Orally Sales Growth Rate Comparison by Type (2022-2028) & (K Units) & (US$ Million)
Table 2. Global Human Vaccines Administered Orally Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million)
Table 3. Global Human Vaccines Administered Orally Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
Table 4. Global Human Vaccines Administered Orally Market Competitive Situation by Manufacturers in 2021
Table 5. Global Human Vaccines Administered Orally Sales (K Units) of Key Manufacturers (2017-2022)
Table 6. Global Human Vaccines Administered Orally Sales Market Share by Manufacturers (2017-2022)
Table 7. Global Human Vaccines Administered Orally Revenue (US$ Million) by Manufacturers (2017-2022)
Table 8. Global Human Vaccines Administered Orally Revenue Share by Manufacturers (2017-2022)
Table 9. Global Market Human Vaccines Administered Orally Average Price (US$/Unit) of Key Manufacturers (2017-2022)
Table 10. Manufacturers Human Vaccines Administered Orally Manufacturing Sites and Area Served
Table 11. Manufacturers Human Vaccines Administered Orally Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Human Vaccines Administered Orally by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Human Vaccines Administered Orally as of 2021)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Human Vaccines Administered Orally Sales by Region (2017-2022) & (K Units)
Table 16. Global Human Vaccines Administered Orally Sales Market Share by Region (2017-2022)
Table 17. Global Human Vaccines Administered Orally Revenue by Region (2017-2022) & (US$ Million)
Table 18. Global Human Vaccines Administered Orally Revenue Market Share by Region (2017-2022)
Table 19. North America Human Vaccines Administered Orally Sales by Country (2017-2022) & (K Units)
Table 20. North America Human Vaccines Administered Orally Sales Market Share by Country (2017-2022)
Table 21. North America Human Vaccines Administered Orally Revenue by Country (2017-2022) & (US$ Million)
Table 22. North America Human Vaccines Administered Orally Revenue Market Share by Country (2017-2022)
Table 23. Europe Human Vaccines Administered Orally Sales by Country (2017-2022) & (K Units)
Table 24. Europe Human Vaccines Administered Orally Sales Market Share by Country (2017-2022)
Table 25. Europe Human Vaccines Administered Orally Revenue by Country (2017-2022) & (US$ Million)
Table 26. Europe Human Vaccines Administered Orally Revenue Market Share by Country (2017-2022)
Table 27. Asia Pacific Human Vaccines Administered Orally Sales by Region (2017-2022) & (K Units)
Table 28. Asia Pacific Human Vaccines Administered Orally Sales Market Share by Region (2017-2022)
Table 29. Asia Pacific Human Vaccines Administered Orally Revenue by Region (2017-2022) & (US$ Million)
Table 30. Asia Pacific Human Vaccines Administered Orally Revenue Market Share by Region (2017-2022)
Table 31. Latin America Human Vaccines Administered Orally Sales by Country (2017-2022) & (K Units)
Table 32. Latin America Human Vaccines Administered Orally Sales Market Share by Country (2017-2022)
Table 33. Latin America Human Vaccines Administered Orally Revenue by Country (2017-2022) & (US$ Million)
Table 34. Latin America Human Vaccines Administered Orally Revenue Market Share by Country (2017-2022)
Table 35. Middle East and Africa Human Vaccines Administered Orally Sales by Country (2017-2022) & (K Units)
Table 36. Middle East and Africa Human Vaccines Administered Orally Sales Market Share by Country (2017-2022)
Table 37. Middle East and Africa Human Vaccines Administered Orally Revenue by Country (2017-2022) & (US$ Million)
Table 38. Middle East and Africa Human Vaccines Administered Orally Revenue Market Share by Country (2017-2022)
Table 39. Global Human Vaccines Administered Orally Sales by Type (2017-2022) & (K Units)
Table 40. Global Human Vaccines Administered Orally Sales Market Share by Type (2017-2022)
Table 41. Global Human Vaccines Administered Orally Revenue by Type (2017-2022) & (US$ Million)
Table 42. Global Human Vaccines Administered Orally Revenue Share by Type (2017-2022)
Table 43. Global Human Vaccines Administered Orally Price by Type (2017-2022) & (US$/Unit)
Table 44. Global Human Vaccines Administered Orally Sales (K Units) by Application (2017-2022)
Table 45. Global Human Vaccines Administered Orally Sales Market Share by Application (2017-2022)
Table 46. Global Human Vaccines Administered Orally Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global Human Vaccines Administered Orally Revenue Share by Application (2017-2022)
Table 48. Global Human Vaccines Administered Orally Price by Application (2017-2022) & (US$/Unit)
Table 49. Merck Corporation Information
Table 50. Merck Description and Business Overview
Table 51. Merck Human Vaccines Administered Orally Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 52. Merck Human Vaccines Administered Orally Product
Table 53. Merck Recent Developments/Updates
Table 54. GSK Corporation Information
Table 55. GSK Description and Business Overview
Table 56. GSK Human Vaccines Administered Orally Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 57. GSK Human Vaccines Administered Orally Product
Table 58. GSK Recent Developments/Updates
Table 59. Sanofi Corporation Information
Table 60. Sanofi Description and Business Overview
Table 61. Sanofi Human Vaccines Administered Orally Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 62. Sanofi Human Vaccines Administered Orally Product
Table 63. Sanofi Recent Developments/Updates
Table 64. Lanzhou Institute Corporation Information
Table 65. Lanzhou Institute Description and Business Overview
Table 66. Lanzhou Institute Human Vaccines Administered Orally Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 67. Lanzhou Institute Human Vaccines Administered Orally Product
Table 68. Lanzhou Institute Recent Developments/Updates
Table 69. Serum Institute Corporation Information
Table 70. Serum Institute Description and Business Overview
Table 71. Serum Institute Human Vaccines Administered Orally Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 72. Serum Institute Human Vaccines Administered Orally Product
Table 73. Serum Institute Recent Developments/Updates
Table 74. Valneva Corporation Information
Table 75. Valneva Description and Business Overview
Table 76. Valneva Human Vaccines Administered Orally Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 77. Valneva Human Vaccines Administered Orally Product
Table 78. Valneva Recent Developments/Updates
Table 79. Shanghai United Cell Corporation Information
Table 80. Shanghai United Cell Description and Business Overview
Table 81. Shanghai United Cell Human Vaccines Administered Orally Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 82. Shanghai United Cell Human Vaccines Administered Orally Product
Table 83. Shanghai United Cell Recent Developments/Updates
Table 84. Bibcol Corporation Information
Table 85. Bibcol Description and Business Overview
Table 86. Bibcol Human Vaccines Administered Orally Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 87. Bibcol Human Vaccines Administered Orally Product
Table 88. Bibcol Recent Developments/Updates
Table 89. PaxVax Corporation Information
Table 90. PaxVax Description and Business Overview
Table 91. PaxVax Human Vaccines Administered Orally Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 92. PaxVax Human Vaccines Administered Orally Product
Table 93. PaxVax Recent Developments/Updates
Table 94. Vabiotech Corporation Information
Table 95. Vabiotech Description and Business Overview
Table 96. Vabiotech Human Vaccines Administered Orally Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 97. Vabiotech Human Vaccines Administered Orally Product
Table 98. Vabiotech Recent Developments/Updates
Table 99. Tiantan Biological Corporation Information
Table 100. Tiantan Biological Description and Business Overview
Table 101. Tiantan Biological Human Vaccines Administered Orally Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 102. Tiantan Biological Human Vaccines Administered Orally Product
Table 103. Tiantan Biological Recent Developments/Updates
Table 104. EuBiologics Corporation Information
Table 105. EuBiologics Description and Business Overview
Table 106. EuBiologics Human Vaccines Administered Orally Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 107. EuBiologics Human Vaccines Administered Orally Product
Table 108. EuBiologics Recent Developments/Updates
Table 109. Panacea Biotec Ltd Corporation Information
Table 110. Panacea Biotec Ltd Description and Business Overview
Table 111. Panacea Biotec Ltd Human Vaccines Administered Orally Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 112. Panacea Biotec Ltd Human Vaccines Administered Orally Product
Table 113. Panacea Biotec Ltd Recent Developments/Updates
Table 114. Bio-Med Corporation Information
Table 115. Bio-Med Description and Business Overview
Table 116. Bio-Med Human Vaccines Administered Orally Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 117. Bio-Med Human Vaccines Administered Orally Product
Table 118. Bio-Med Recent Developments/Updates
Table 119. Halfkin Bio-Pharmaceuticals Corporation Information
Table 120. Halfkin Bio-Pharmaceuticals Description and Business Overview
Table 121. Halfkin Bio-Pharmaceuticals Human Vaccines Administered Orally Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 122. Halfkin Bio-Pharmaceuticals Human Vaccines Administered Orally Product
Table 123. Halfkin Bio-Pharmaceuticals Recent Developments/Updates
Table 124. Production Base and Market Concentration Rate of Raw Material
Table 125. Key Suppliers of Raw Materials
Table 126. Human Vaccines Administered Orally Distributors List
Table 127. Human Vaccines Administered Orally Customers List
Table 128. Human Vaccines Administered Orally Market Trends
Table 129. Human Vaccines Administered Orally Market Drivers
Table 130. Human Vaccines Administered Orally Market Challenges
Table 131. Human Vaccines Administered Orally Market Restraints
Table 132. Global Human Vaccines Administered Orally Sales Forecast by Type (2023-2028) & (K Units)
Table 133. Global Human Vaccines Administered Orally Sales Market Share Forecast by Type (2023-2028)
Table 134. Global Human Vaccines Administered Orally Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 135. Global Human Vaccines Administered Orally Revenue Market Share Forecast by Type (2023-2028)
Table 136. Global Human Vaccines Administered Orally Sales Forecast by Application (2023-2028) & (K Units)
Table 137. Global Human Vaccines Administered Orally Sales Market Share Forecast by Application (2023-2028)
Table 138. Global Human Vaccines Administered Orally Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 139. Global Human Vaccines Administered Orally Revenue Market Share Forecast by Application (2023-2028)
Table 140. Global Human Vaccines Administered Orally Sales Forecast by Region (2023-2028) & (K Units)
Table 141. Global Human Vaccines Administered Orally Sales Market Share Forecast by Region (2023-2028)
Table 142. Global Human Vaccines Administered Orally Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 143. Global Human Vaccines Administered Orally Revenue Market Share Forecast by Region (2023-2028)
Table 144. Research Programs/Design for This Report
Table 145. Key Data Information from Secondary Sources
Table 146. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Human Vaccines Administered Orally
Figure 2. Global Human Vaccines Administered Orally Market Share by Type in 2021 & 2028
Figure 3. Rotavirus Vaccine Product Picture
Figure 4. Cholera Vaccine Product Picture
Figure 5. Oral Polio Vaccine Product Picture
Figure 6. Global Human Vaccines Administered Orally Market Share by Application in 2021 & 2028
Figure 7. Public
Figure 8. Private
Figure 9. Global Human Vaccines Administered Orally Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 10. Global Human Vaccines Administered Orally Market Size (2017-2028) & (US$ Million)
Figure 11. Global Human Vaccines Administered Orally Sales (2017-2028) & (K Units)
Figure 12. Human Vaccines Administered Orally Sales Share by Manufacturers in 2021
Figure 13. Global Human Vaccines Administered Orally Revenue Share by Manufacturers in 2021
Figure 14. The Global 5 and 10 Largest Human Vaccines Administered Orally Players: Market Share by Revenue in 2021
Figure 15. Human Vaccines Administered Orally Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 16. Global Human Vaccines Administered Orally Sales Market Share by Region (2017-2022)
Figure 17. Global Human Vaccines Administered Orally Sales Market Share by Region in 2021
Figure 18. Global Human Vaccines Administered Orally Revenue Market Share by Region (2017-2022)
Figure 19. Global Human Vaccines Administered Orally Revenue Market Share by Region in 2021
Figure 20. United States Human Vaccines Administered Orally Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 21. Canada Human Vaccines Administered Orally Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 22. Germany Human Vaccines Administered Orally Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 23. France Human Vaccines Administered Orally Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 24. U.K. Human Vaccines Administered Orally Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 25. Italy Human Vaccines Administered Orally Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 26. Russia Human Vaccines Administered Orally Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 27. China Human Vaccines Administered Orally Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 28. Japan Human Vaccines Administered Orally Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 29. South Korea Human Vaccines Administered Orally Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 30. India Human Vaccines Administered Orally Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 31. Australia Human Vaccines Administered Orally Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 32. China Taiwan Human Vaccines Administered Orally Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 33. Indonesia Human Vaccines Administered Orally Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 34. Thailand Human Vaccines Administered Orally Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 35. Malaysia Human Vaccines Administered Orally Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 36. Mexico Human Vaccines Administered Orally Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 37. Brazil Human Vaccines Administered Orally Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 38. Argentina Human Vaccines Administered Orally Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 39. Turkey Human Vaccines Administered Orally Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 40. Saudi Arabia Human Vaccines Administered Orally Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 41. UAE Human Vaccines Administered Orally Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 42. Sales Market Share of Human Vaccines Administered Orally by Type (2017-2022)
Figure 43. Manufacturing Cost Structure of Human Vaccines Administered Orally
Figure 44. Manufacturing Process Analysis of Human Vaccines Administered Orally
Figure 45. Human Vaccines Administered Orally Industrial Chain Analysis
Figure 46. Channels of Distribution
Figure 47. Distributors Profiles
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs